Navigation Links
Spectral announces 2007 financial results




Weighted average number of common

shares outstanding 24,117,333 22,874,694



Spectral Diagnostics Inc.

Statements of Cash Flows


(in thousands of dollars)

Year Nine months

ended ended

December December

31, 2007 31, 2006

$ $

Cash provided by (used in)

Operating activities

Net (loss) income and comprehensive (loss)

income for the period (1,666) 3,730

Items not affecting cash

Amortization 588 580

Amortization of commercial instruments

included in cost of sales 11 12

Loss on disposal of property, plant

and equipment 46 -

Write off of purchased technology

and trademarks 66 -

Stock-based compensation expense 117 358

Interest on convertible notes payable 165 288

Gain on settlement of convertible

notes payable - (5,363)

Changes in non-cash workin

SOURCE Spectral Diagnostics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
2. US Patent and Trademark Office Allows CRis Patent Application for Spectral Imaging of Deep Tissue
3. CRi Announces Nuance 2, the Next-Generation Multispectral Imaging System for Brightfield and Fluorescent-Based Microscopy
4. Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
5. Spectral appoints Anthony Bihl to Board of Directors
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
(Date:7/10/2014)... 2014 EvoDerma ’s NOOME Anti-Aging Motion ... device now comes with a second treatment cup to help ... The new cup is thinner on the edges for a ... rough, thin and uneven surfaces on the face, neck and ... stimulating treatment on areas such as the cheeks and neck, ...
(Date:7/10/2014)...  Kainos Capital, a firm specializing in acquiring and ... has acquired the Slim-Fast brand from Unilever. Unilever will ... the transaction were not disclosed. Slim-Fast is ... markets ready-to-drink shakes, powders, bars and snacks to retail ... in the United Kingdom and ...
(Date:7/10/2014)... WASHINGTON D.C., April 15, 2014 -- According to ... danger to nuclear security comes from terrorists acquiring ... (HEU) to construct a crude nuclear explosive device. ... illicit nuclear trafficking have involved gram-level quantities, which ... methods. , According to a new study appearing ...
(Date:7/10/2014)... basis of psychiatric disorders has been extremely challenging because ... but are insufficient to cause disease. Now investigators reporting ... journal Cell Stem Cell describe a strategy ... interact with other risk factors or environmental exposures to ... pinpoints a genetic variant that may predispose individuals to ...
Breaking Biology Technology:Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Kainos Capital Acquires Slim-Fast From Unilever 2Sensitive detection method may help impede illicit nuclear trafficking 2New strategy could uncover genes at the root of psychiatric illnesses 2
... expands Dermagraft presence within government channels, ... 7 Advanced,BioHealing, Inc. (ABH) and Regenesis ... the promotion of Dermagraft(R) within the United,States ... the agreement,Regenesis will provide its specialized sales ...
... this Mother,s Day, STAMFORD, Conn., May 7 Every ... breast cancer(1). In New York City alone,more than 5,000 women ... the disease(2). While annual mammograms are recommended for,woman over the ... screening age do,not recognize how critical breast cancer screening is ...
... Inc., Elliott Sigal, M.D., Ph.D, from Bristol-Myers Squibb Company, Federico ... FDA, ... IBC Life Sciences announced,the keynote line up for the ... to take place August 4-7, 2008 in,Boston, MA. The keynote ...
Cached Biology Technology:Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R) 2Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R) 3Fujifilm and the National Breast Cancer Foundation Provide Free Mammograms as Part of Images of Health Campaign 2Fujifilm and the National Breast Cancer Foundation Provide Free Mammograms as Part of Images of Health Campaign 3Fujifilm and the National Breast Cancer Foundation Provide Free Mammograms as Part of Images of Health Campaign 4Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBC's 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress 2
(Date:7/11/2014)... Tenn., July 11, 2014--Researchers at the Department of ... R&D 100 awards, presented by R&D Magazine in ... , "These awards recognize the tremendous value of ... Moniz. "Research and development at the National Labs ... challenges and pursue the scientific and technological innovations ...
(Date:7/11/2014)... a new professorship in tissue engineering to promote ... Engineering and the Marine Biological Laboratory, supported by ... Eugene Bell Foundation., The Eugene Bell Professorship in ... Molecular Engineering. That endowed chair holder also will ... Bell Center for Regenerative Biology and Tissue Engineering, ...
(Date:7/11/2014)... 10, 2014---A team of researchers from The Chinese University ... a gene of wild soybean linked to salt tolerance, ... in saline soil. This study published online in ... novel genomic information for crop improvement. , Soybean is ... and human selection, cultivated soybeans have less genetic diversities ...
Breaking Biology News(10 mins):ORNL wins eight R&D 100s 2ORNL wins eight R&D 100s 3ORNL wins eight R&D 100s 4New professorship in tissue engineering links molecular engineering, marine biology 2BGI reports a novel gene for salt tolerance found in wild soybean 2
... UK, July 20, 2011 - Recent clinical research ... [18F]Flutemetamol showed highly consistent image interpretation1 and showed ... ([C-11]PiB)) investigational imaging agent3. Flutemetamol is a GE ... currently in phase III development being studied for ...
... an arterial wall effectively protects the artery from developing ... published July 19 in the journal Molecular Therapy ... atherosclerosis, fatty lesions called plaques form on the inner ... restricting blood flow and causing chest pains and other ...
... A new Baylor University study has found that some bird ... some cases positively influenced, by widespread fire through their habitat. ... some bird species because of the habitat that is formed ... The study found that three specific bird species in ...
Cached Biology News:GE Healthcare studies report results of [18F]Flutemetamol research 2Gene therapy delivered once to blood vessel wall protects against atherosclerosis in rabbit studies 2Gene therapy delivered once to blood vessel wall protects against atherosclerosis in rabbit studies 3Gene therapy delivered once to blood vessel wall protects against atherosclerosis in rabbit studies 4Study finds some desert birds less affected by wildfires and climate change 2
Alkali soluble casein is the recommended blot blocking reagent for use with the HisTag Monoclonal Antibody (Novagen) on Western blots....
... This reagent has been developed for ... the reduction of nonspecific background staining ... methods describe blocking peroxidase with hydrogen ... peroxide in combination with additional novel ...
Anti-Human Factor XI Purified (Polyclonal) (sheep IgG)...
Formulation: 10mM PBS/500 mM NaCl, 0.09% NaN3, pH 7.2...
Biology Products: